Dublin, May 01, 2017 -- Research and Markets has announced the addition of the "Global Roaming Tariff Tracker and Analysis" newsletter to their offering.
The Global Roaming Tariff Tracker is a subscription service published 4 times a year (January, April, July & October) and provides an excel-based database of voice, SMS & mobile data roaming from 90 MNOs worldwide in 64 countries updated every quarter.
Pricing is shown in local currencies, USD and Euro. With each edition it provides a PDF summary of new roaming products and pricing since the last quarter period.
Roaming prices have confronted criticism in recent years and are undergoing significant changes at this present time. The European Commission has imposed regulation to the pricing of voice roaming charges and it saw the introduction of capped wholesale and retail voice prices for calls made within the EU on 30th August 2007, followed by capped SMS prices in July 2009 and wholesale and retail data prices also with further prices changes each year thereafter including SMS. Roaming is to be abolished in the EU at the end of 2015, with many operators already offering roam like home options.
Roaming especially in the consumer market has been perceived as complex and expensive, despite operators having moved to attractive on-net pricing and easier-to-understand pricing structures, roaming prices often still hit the headlines with users especially when using data, receive invoices of high amounts.
Findings reveal that offerings have increased through the launch of bundles and special schemes for both voice and data services. Both voice and data calls price changes have been mainly downward with some operators increasing rates to non-European destinations. Operators continue to seek to introduce innovative offers to help for the compensation of the potential loss in revenue from the imposed regulation.
Services (both postpaid and prepaid) and prices covered include:
Default (standard roaming) prices for:
- Calling back home
- Calling within a country
- Receiving a call
- Sending an SMS
- Accessing the Internet
- Details of Zoning
Pricing details of bundled offerings:
- Voice Bundles
Cost, Validity, inclusive allowance, inside and outside the bundle price & comments)
- Data Bundles
Cost, Validity, inclusive allowance, inside and outside the bundle price & comments)
- Integrated Bundles
Cost, Validity, inclusive allowances (Voice, SMS, Data) and comments
- Roam like Home Offerings
Cost, Validity, prices and comments
For more information about this newsletter visit http://www.researchandmarkets.com/research/kdn53h/global_roaming
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Mobile Networks


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



